E
Regen BioPharma, Inc. RGBP
$0.026 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -967.00K -929.80K -1.03M -662.40K -722.50K
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 33.80K 45.50K 37.20K 29.00K 13.90K
Total Other Non-Cash Items 632.10K 159.90K 159.90K 154.70K 252.60K
Change in Net Operating Assets -71.40K 235.30K 238.60K -214.40K -111.60K
Cash from Operations -372.50K -489.10K -597.20K -693.10K -567.60K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 243.80K 187.80K 84.90K 19.10K 143.80K
Total Debt Repaid 40.50K 61.50K 36.50K -10.00K -50.50K
Issuance of Common Stock 28.10K 163.40K 351.30K 563.60K 535.50K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 312.50K 412.80K 472.80K 572.80K 628.80K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments 0.00 0.00 0.00 0.00 0.00
Net Change in Cash -60.10K -76.40K -124.40K -120.30K 61.10K